SCHEMBL6602596

SCHEMBL6602596

CCOC(=O)c1nc2cc(F)c([N+](=O)[O-])cc2nc1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MITF O75030 2/20 0.41
LMNA P02545 2/20 0.41
GALR2 O43603 1/20 0.41
POLB P06746 1/20 0.41
HSP90AA1 P07900 1/20 0.41
HPGD P15428 1/20 0.41
XBP1 P17861 1/20 0.41
CCR6 P51684 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 7/20 0.39
GLP1R P43220 1/20 0.39
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6377194 0.91 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MITFLMNAGALR2
SCHEMBL6380676 0.91 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MITFLMNAGALR2
SCHEMBL6607045 0.88 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2MITFLMNAGALR2
SCHEMBL6603312 0.83 KCNMA1 (0.38) SMN1; SMN2LMNAGALR2POLBMAPT
SCHEMBL6604726 0.82 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2MITFLMNAGALR2
SCHEMBL8369082 0.81 PPARG (0.43) ALDH1A1SMN1; SMN2MITFLMNAPOLB
SCHEMBL5722679 0.81 POLB (0.45) ALDH1A1LMNAGALR2POLBHPGD
SCHEMBL6601452 0.81 GLP1R (0.41) ALDH1A1SMN1; SMN2HPGDMAPTGLP1R
SCHEMBL6607136 0.79 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2MITFLMNAGALR2
SCHEMBL6603316 0.79 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2MITFLMNAGALR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1020453-B1 6,7-ASYMMETRICALLY DISUBSTITUTED QUINOXALINECARBOXYLIC ACID DERIVATIVES, ADDITION SALTS THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN SEIYAKU KK (JP) 2004-05-19 EP disclosed
US-6348461-B1 CENTRAL NERVOUS SYSTEM ANTAGONIST WITH HETEROCYCLIC SUBSTITUENTS KYORIN PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1020453-A1 6,7-ASYMMETRICALLY DISUBSTITUTED QUINOXALINECARBOXYLIC ACID DERI VATIVES, ADDITION SALTS THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed